The upcoming Braintree contract renegotiations with big tech players could bring more downside than upside in the near term ...
West Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, ...
Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results